Second Sight Medical Products has a Cash Ratio of 21.76. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Second Sight Medical Products's Cash Ratio or its related term are showing as below:
EYESW'
s Cash Ratio Range Over the Past 10 Years
Min: 0.43 Med: 2.33 Max: 28.27
Current: 21.76
During the past 10 years, Second Sight Medical Products's highest Cash Ratio was 28.27. The lowest was 0.43. And the median was 2.33.
EYESW's Cash Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.23
vs EYESW: 21.76
Second Sight Medical Products Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Second Sight Medical Products's Cash Ratio
For the Medical Devices subindustry, Second Sight Medical Products's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Second Sight Medical Products's Cash Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Second Sight Medical Products's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Second Sight Medical Products's Cash Ratio falls into.
Second Sight Medical Products Cash Ratio Calculation
The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Second Sight Medical Products (NAS:EYESW) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Second Sight Medical Products Cash Ratio Related Terms
Thank you for viewing the detailed overview of Second Sight Medical Products's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Second Sight Medical Products (Second Sight Medical Products) Business Description
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.
Second Sight Medical Products (Second Sight Medical Products) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EYESW has been successfully added to your 